AKT1 and cancer: As we mentioned in the previous treatment section, Tel has been confirmed to down-regulate the expression of FOXA1 through the IGF1-R/AKT/FOXA1 pathway, to inhibit the proliferation of cancer cells in ER-positive breast cancer.